Power of the eternal youth: Nanog expression in the gestational choriocarcinoma

American Journal of Pathology

Volumn 173, Issue 4, 2008, Pages 911-914

  Shih, Ie Ming ^a   Kuo, Kuan Ting ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; TRANSCRIPTION FACTOR NANOG;

ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; CANCER SURGERY; CARCINOGENICITY; CHORIOCARCINOMA; CYTOTOXICITY; CYTOTROPHOBLAST; EMBRYONIC STEM CELL; GESTATIONAL CHORIOCARCINOMA; HUMAN; HYDATIDIFORM MOLE; NONHUMAN; NOTE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RNA INTERFERENCE; SYNCYTIOTROPHOBLAST; TROPHOBLAST; TROPHOBLASTIC TUMOR;

EID: 53149098601     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2008.080624     Document Type: Note

References (23)

1. Shih IM: Gestational trophoblastic neoplasms - pathogenesis and potential therapeutic targets. Lancet Oncol 2007, 8:642-650
2. Mao TL, Kurman RJ, Huang C, Lin MC, Shih I-M: Immunohistochemistry of choriocarcinoma: an aid in differential diagnosis and in elucidating pathogenesis. Am J Surg Pathol 2007, 31:1726-1732
3. Jeffers MD, Richmond JA, Smith R: Trophoblast proliferation rate does not predict progression to persistent gestational trophoblastic disease in complete hydatidiform mole. Int J Gynecol Pathol 1996, 15:34-38
4. Cheung AN, Ngan HY, Chen WZ, Loke SL, Collins RJ: The significance of proliferating cell nuclear antigen in human trophoblastic disease: an immunohistochemical study. Histopathology 1993, 22:565-568
5. Siu MKY, Wong ESY, Chan H-Y, Ngan HYS, Chan KY, Cheung AN: Overexpression of NANOG in gestational trophoblastic diseases - effect on apoptosis, cell invasion, and clinical outcome. Am J Pathol 2008, 173:1165-1172
6. Asanoma K, Matsuda T, Kondo H, Kato K, Kishino T, Niikawa N, Wake N, Kato H: NECC1, a candidate choriocarcinoma suppressor gene that encodes a homeodomain consensus motif. Genomics 2003, 81:15-25
7. Garrido C, Ottavi P, Fromentin A, Hammann A, Arrigo AP, Chauffert B, Mehlen P: HSP27 as a mediator of confluence-dependent resistance to cell death induced by anticancer drugs. Cancer Res 1997, 57:2661-2667
8. Tuncer ZS, Vegh GL, Fulop V, Genest DR, Mok SC, Berkowitz RS: Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor. Gynecol Oncol 2000, 77:389-393
9. Fulop V, Colitti CV, Genest D, Berkowitz RS, Yiu GK, Ng SW, Szepesi J, Mok SC: DOC-2/hDab2, a candidate tumor suppressor gene involved in the development of gestational trophoblastic diseases. Oncogene 1998, 17:419-424
10. Ståhle-Bäckdhal M, Inoue M, Zedenius J, Sandstedt B, DeMarco L, Flam F, Silfversward C, Andrade J, Friedman E: Decreased expression of Ras GTPase activating protein in human trophoblastic tumors. Am J Pathol 1995, 146:1073-1078
11. Xue WC, Chan KY, Feng HC, Chiu PM, Ngan HY, Tsao SW, Cheung AN: Promoter hypermethylation of multiple genes in hydatidiform mole and choriocarcinoma. J Mol Diagn 2004, 6:326-334
12. Adjaye J, Huntriss J, Herwig R, BenKahla A, Brink TC, Wierling C, Hultschig C, Groth D, Yaspo ML, Picton HM, Gosden RG, Lehrach H: Primary differentiation in the human blastocyst: comparative molecular portraits of inner cell mass and trophectoderm cells. Stem Cells 2005, 23:1514-1525
13. Jiang J, Chan YS, Loh YH, Cai J, Tong GQ, Lim CA, Robson P, Zhong S, Ng HH: A core Klf circuitry regulates self-renewal of embryonic stem cells. Nat Cell Biol 2008, 10:353-360
14. Samaniego F, Rodriguez E, Houldsworth J, Murty VV, Ladanyi M, Lele KP, Chen QG, Dmitrovsky E, Geller NL, Reuter V: Cytogenetic and molecular analysis of human male germ cell tumors: chromosome 12 abnormalities and gene amplification. Genes Chromosom Cancer 1990, 1:289-300
15. Zhang SBC, Chan MW, Lai HC, Matei D, Schilder JM, Yan PS, Huang TH, Nephew KP: Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res 2008, 68:4311-4320
16. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A, Weinberg RA: An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 2008, 40:499-507
17. Gu G, Yuan J, Wills M, Kasper S: Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. Cancer Res 2007, 67:4807-4815
18. Shih IM, Kurman RJ: p63 expression is useful in the distinction of epithelioid trophoblastic and placental site trophoblastic tumors by profiling trophoblastic subpopulations. Am J Surg Pathol 2004, 28:1177-1183
19. Li HW, Cheung AN, Tsao SW, Cheung AL: Expression of e-cadherin and beta-catenin in trophoblastic tissue in normal and pathological pregnancies. Int J Gynecol Pathol 2003, 22:63-70
20. Shih I-M: Trophogram, an immunohistochemistry-based algorithmic approach, in the differential diagnosis of trophoblastic tumors and tumorlike lesions. Ann Diagn Pathol 2007, 11:228-234
21. Shih I-M, Kurman RJ: Molecular basis of gestational trophoblastic diseases. Curr Mol Med 2002, 2:1-12
22. Shih I-M, Kurman RJ: Epithelioid trophoblastic tumor - a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma. Am J Surg Pathol 1998, 22:1393-1403
23. Guo Y, Mantel C, Hromas RA, Broxmeyer HE: Oct-4 is critical for survival/antiapoptosis of murine embryonic stem cells subjected to stress: effects associated with Stat3/survivin. Stem Cells 2008, 26:30-34